ACADIAN ASSET MANAGEMENT LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$26
-10.3%
1,4440.0%0.00%
Q4 2022$29
-100.0%
1,444
-71.2%
0.00%
-100.0%
Q2 2021$137,000
-43.2%
5,022
-41.6%
0.00%0.0%
Q1 2021$241,000
+249.3%
8,598
+223.2%
0.00%
Q4 2020$69,000
+187.5%
2,660
+178.8%
0.00%
Q2 2020$24,000
-42.9%
954
-68.5%
0.00%
Q1 2020$42,000
-40.0%
3,033
-60.7%
0.00%
Q3 2019$70,0007,7080.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders